Mesothelioma. Mesothelioma and Asbestos 11/21/2009



Similar documents
A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes

PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON*

Francine Lortie-Monette, MD, MSc, CSPQ, MBA Department of Epidemiology and Biostatistics University of Western Ontario 2003

Lessons learned from the Western Australian experience with mesothelioma

Pathogenesis and Diagnosis of Mesothelioma

Survey on the Mortality from Malignant Tumors of Female Asbestos Spinning Workers

BE.104 Spring Evaluating Environmental Causes of Mesothelioma J. L. Sherley

Asbestos & Cancer: An Update. Suresh H. Moolgavkar, M.D., Ph.D.

Cancer Risk Factors in Ontario. Dusts and Fibres

Griffith University - Case for Support. Mesothelioma Research Program

Screening, early referral and treatment for asbestos related cancer

Scientific Update on Safe Use of Asbestos. Robert P. Nolan, PhD International Environmental Research Foundation New York, New York

- Compensation issues

Mesothelioma incidence modeling and forecasting

THE TIMES OF OCCURRENCE OF MESOTHELIOMAS IN RATS FOLLOWING INOCULATION WITH ASBESTOS

Genetic Predisposition to Fiber Carcinogenesis Causes a Mesothelioma Epidemic in Turkey

Influence of Fiber Type, Size, and Number in Human Disease: Conclusions from Fiber Burden Analysis

Lung cancer and asbestos

Elimination of Asbestos- Related Diseases WHO action. Dr Ivan D. Ivanov Public Health and Environment WHO Headquarters

L Lang-Lazdunski, A Bille, S Marshall, R Lal, D Landau, J Spicer

co-sponsored by the Health & Physical Education Department, the Health Services Office, and the Student Development Center

The Public Health Management of Chemical Incidents Case Study

Basic Study Designs in Analytical Epidemiology For Observational Studies

Targeting Specific Cell Signaling Pathways for the Treatment of Malignant Peritoneal Mesothelioma

Chemical and Morphological Comparison of Erionite from Oregon, North Dakota, and Turkey

Table 2.4. Summary of design and findings from mesothelioma case-control studies

Asbestos Health Risks. Dr Andrew Pengilley Acting Chief Health Officer

Asbestos in the Home MISAWA AB, JAPAN

Erionite exposure in North Dakota and Turkish villages with mesothelioma

Asbestos Diseases. What Is Asbestos?

Asbestos: health effects and risk. Peter Franklin Senior Scientific Officer, EHD Senior Research Fellow, UWA

Personalized Treatment for Malignant Mesothelioma

Plaintiffs Experts Latest Pathological Theories

Asbestos at the Work Site

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1

Mesothelioma: Questions and Answers

HEALTH EFFECTS. Inhalation

Health effects of occupational exposure to asbestos dust

What is Cancer? Cancer is a genetic disease: Cancer typically involves a change in gene expression/function:

Review of Eliminating occupational cancer in Europe and globally by J. Takala

Big Data for Population Health and Personalised Medicine through EMR Linkages

Update on Clinical Trials and Foundation Funded Grants

Increasing mesothelioma deaths amongst school staff and former pupils

BY THE NUMBERS: THE FUTURE OF MESOTHELIOMA IN AMERICA

Carcinogens in the Construction Industry

Occupational respiratory diseases due to Asbestos. Dirk Dahmann, IGF, Bochum

NISG Asbestos. Caroline Kirton

Malignant Mesothelioma

Malignant Mesothelioma

Testimony of. Dr. James Crapo. April 26, 2005

The Burden of Occupational Lung Cancer Paul A. Demers, PhD

IWU PHYSICAL PLANT SAFETY PROGRAM. Toxic and Hazardous Substances, Title 29 Code of Federal Regulations (CFR) Part , Subpart Z Asbestos

Mesothelioma , The Patient Education Institute, Inc. ocft0101 Last reviewed: 03/21/2013 1

Advances in Treatment of Malignant Pleural Mesothelioma: A Reason for Hope

EFFECT OF CHILDREN'S AGE AND LIFE EXPECTATION ON MESOTHELIOMA RISK 1

Asbestos-Related Cancer Research and Prevention

Current Usage and Health Significance of the Modern Use of Chrysotile Products: Review of Recently Published Evidence

Asbestos related cancers

NHS Barking and Dagenham Briefing on disease linked to Asbestos in Barking & Dagenham

Malignant Mesothelioma: an Update

Workers around the world who encounter hazardous substances are aware of the measures needed

ANNEX 2: Assessment of the 7 points agreed by WATCH as meriting attention (cover paper, paragraph 9, bullet points) by Andy Darnton, HSE

CHAPTER 2: UNDERSTANDING CANCER

Health Effects of Asbestos Exposure

Executive summary. Background

How To Determine The Risk Of Mesothelioma In Brake Workers

Asbestos risks, safety and its role in lung disease

Early Detection Research Network: Validation Infrastructure. Jo Ann Rinaudo, Ph.D. Division of Cancer Prevention

بسم هللا الرحمن الرحيم

ASBESTOS AWARENESS. For workers and building occupants

Primary reason asbestos is used, is its special resistance to heat. Asbestos fibers are also virtually indestructible.

ROUND TABLE ADVANCES IN OCCUPATIONAL CANCER

OCCUPATIONAL LUNG CANCER

FREQUENTLY ASKED QUESTIONS about asbestos related diseases

Pleural Mesotheliomas in Sprague-D~wley Rats by Erionite: First Experimental Evidence

Asbestos and Mesothelioma a briefing document for the Metropolitan Police

Science-Based Facts Relevant Health Issues For environmental occupational health safe and responsible use

Asbestos and Health WHO recommendations on elimination of asbestos-related diseases

Future Trends of Mesothelioma Mortality in Japan Based on a Risk Function

Nuevas tecnologías basadas en biomarcadores para oncología

ORIGINAL ARTICLE. Serum Levels of Alpha-Tocopherol, Vitamin C, Beta-Carotene, and Retinol in Malignant Pleural Mesothelioma

Sir William Osler: Listen to the patient; the patient tells you everything.

Asbestos is a naturally occurring mineral, with many physical forms, of which the three most important are:

Occupational Disease Fatalities Accepted by the Workers Compensation Board

Asbestos and Mesothelioma in Ontario

HEALTH CARE FOR EXPOSURE TO ASBESTOS The SafetyNet Centre for Occupational Health and Safety Research Memorial University

LESSON 3.5 WORKBOOK. How do cancer cells evolve? Workbook Lesson 3.5

Changing Trends in Mesothelioma Incidence. Hans Weill, M.D. Professor of Medicine Emeritus Tulane University Medical Center

Varianti genetiche e interazione gene-asbesto nel mesotelioma pleurico

Mesothelioma in Northeastern Minnesota and Two Occupational Cohorts: 2007 Update. December 7, 2007

Mesothelioma in Northeastern Minnesota and Two Occupational Cohorts: 2007 Update. December 7, 2007

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing

Genomic Analysis of Mature B-cell Malignancies

Toxicity of Amphibole Asbestos

What has changed to justify the US Senate s bill to ban asbestos now?

Asbestos Presence in a Factory that Produced Asbestos-Containing Products

Transcription:

Mesothelioma Michele Carbone, M.D.,PH.D. Director Cancer Research Center of Hawaii Professor and Chairman, Dept. of Pathology J.A. Burns Medical School University of Hawaii Honolulu, HI 96813 Mesotheliomas were extremely rare until the second half of the 20th century Currently, there are approximately 2-3000 cases of mesothelioma/year in the USA Therefore, mesotheliomas are caused by a carcinogen that humans have just recently been exposed to, or exposed to in increasing amounts Mesothelioma and Asbestos The link between asbestos exposure and mesothelioma is well established Up to 5% of crocidolite miners developed mesothelioma Most mesotheliomas patients have exposures above background 1

TABLE 1. Asbestos exposure and human diseases based on lung content analysis Asbestos and Mesothelial cells Normal human mesothelial cells (HM) HM Exposed to Crocidolite Asbestos @ Fibers/gX10 3, (uncoated fibers, mostly amosite 53 ); *million of fibers/dry Lung; # Fibers X10 6 /g dry lung. PTL-MM, peritoneal malignant mesothelioma Asbestos causes Human Mesothelial cells (HM) death in vitro. Research question TNF-α and its receptor TNF-R1 is induced in HM following asbestos exposure. How can asbestos cause malignant mesothelioma (MM) if human mesothelial cells (HM) exposed to asbestos die? 2

Finding mechanism of asbestos carcinogenesis Asbestos and TNF-α TNF-α signaling through NF-κB-dependent mechanisms increases the percent of HM that survives asbestos exposure, thus increasing the pool of asbestos-damaged HM that are susceptible to malignant transformation. crocidolite crocidolite+tnf-α (Yang et al, PNAS 2006) Asbestos + TNF-α (after 1 M) HM and macrophages co-culture 3 weeks 1.5 month 3

11/21/2009 TNF-a inhibits asbestos induced cytotoxicity via a NF-kB dependent pathway: a possible mechanism for asbestos induced oncogenesis. Yang H, Bocchetta M, Kroczynska B, Elmishad AG, Chen Y, Liu Z, Bubici C, Mossman BT, Pass HI, Testa JR, Franzoso G and Carbone M, Proceedings of the National Academy of Sciences USA, 2006. 4

Karain Tuzkoy Old Sarihidir 5

6

Karlik: 3 Km from Karain 7

Erionite and Mesothelioma We spent the following 3 years in Karain, Tuzkoy, and Karlik collecting data about: eating habits, occupation, smoking, family life style, family pedigrees, medical histories, etc. Drs. Dogan and Steele determined the chemical and crystal structure of erionite in Cappadocia My office in Sarihidir Erionite and Mesothelioma Similar amounts and types of erionite in Karlik and Karain, Tuzkoy and Sarihidir Similar amounts of erionite in the houses of Karain and Tuzkoy The chemical and crystal structure confirmed that erionite in Cappadocia is similar to the erionite found in the USA 8

My office in Karain 9

Mesothelioma Mesothelioma is a cancer in which genetics, environmental carcinogens, and viruses may act alone or interact to cause malignancy The isolation of the putative mesotheliomasusceptibility gene/s is the key to understand the precise pathogenesis of mesothelioma and to develop effective therapeutic approaches This is the main goal of our PO-1 Pathogenesis of mesothelioma, 2006-2011, M. Carbone PI. Louisiana Pedigree Localization of a Dominant Genetic Susceptibility Factor in Familial Malignant Mesothelioma Genotyping and Quality Control All available family members have been genotyped using the Affymetrix Genome- Wide Human SNP Array 6.0. Prior to linkage analyses, familial relationships were checked and corrected using PLINK. The results should allow us to identify the gene/s that make certain family members susceptible to MM. Problem: Insufficient number of DNA samples from affected individuals. 10

What should we do in the meantime Goal of my research: identify some point in the evolution of the (mesothelioma) process that is vulnerable to intervention : Diminish exposure Old Sarihidir 11

New Sarihidir The new village of Tuzkoy Did we really diminish erionite exposure in New Tuzkoy? Were the air concentration of erionite in new Tuzkoy significantly lower than in other mesothelioma villages? I started a collaboration with the EPA to measure air concentration of erionite and test this hypothesis Team-April 08 12

New Tuzkoy Village Field sampling consider significant increases in airborne particulate after Industrialization: tractors vs horses, or more primitive farming tools that would not stir up as much dust. 13

What about them? What should we do in the meantime Goal of my research: identify some point in the evolution of the (mesothelioma) process that is vulnerable to intervention : Diminish exposure. Done identify high risk patients for early treatment Asbestos exposure, mesothelioma, and serum osteopontin levels. Pass HI, Lott D, Leonardo F., Harbut M, Liu Z, Tang M., M. Carbone, et al., New Engl J Med, 2005. 14

Early detection: Can we save lives? The Cappadocian villages are the ideal cohort that may benefit from the availability of early markers for MM. We applied to the EDRN to conduct a 4 year prospective study to validate Osteopontin and Mesothelin as early markers for the detection of mesothelioma. We asked the Turkish Ministry of Health to build a mesothelioma referral clinic in Cappadocia to provide logistical support for our study and to help the villagers. The outcome was positive. We got both, the grant and the hospital. Aug 15, 07 meeting in Honolulu. April 2008 meeting in Tuzkoy: Health Center is ready. Sample size Based on an estimated incidence of mesothelioma of 1.5/100 per year, we would expect 6 individuals in a cohort of 400 would develop mesothelioma each year. To conduct a similar study in the US with an incidence of MM of about 10/1,000,000 we would need to study approximately 600,000 people for 4 years! The results will possibly benefit the Turkish villagers AND many million people exposed to asbestos and to other carcinogenic mineral fibers in the US and worldwide. 1. Baseline Activity Study Design 400 villagers: blood collection (for both serum and plasma); CT scan -- to determine whether they have non-diagnosed MM. 400 Control: age-matched, sex-matched, and tobacco-matched controls from the University of Hacettepe in Ankara establish baseline geographical differences in markers between exposed villagers and non-exposed Turks. SMRP will be tested in serum, osteopontin will be tested in both serum and plasma. 50 of the study participants will be randomly selected to be members of the sub cohort for additional activities during the follow-up visits. 15

Conclusions Erionite Occurrences in the Western U.S. 1. The Turkish cohort is ideal to study gene environment interaction and cancer and to try to isolate the gene tht predisposes to mineral fiber carcinogenesis. 2. The MM villages in Cappadocia have an ideal cohort to test the clinical relevance of early detection markers for MM and Cancer. 3. In addition this research shows how research in a third world country can benefit patients in both the third world and the US 4. Finally we show that research can be a positive political ambassador for the US in Muslim countries. 5. The results of the studies are relevant to the villagers and to millions of people worldwide exposed to asbestos and erionite. 6. IN FACT. Sheppard, 1996, Occurrences of erionite in sedimentary rocks of the western United States Erionite in the US Active Funding, M.Carbone PI Pathogenesis of Mesothelioma: NCI-PO-1 (JR Testa, B Mossman, and HI Pass co-pis) 2007-2012 Mechanisms of SV40 asbestos-co-carcinogenesis in mesothelioma: NCI RO-1 2005-2010 SV40 in human tumors: NCI RO-1 2003-2009. AACR Landon Innovator Award for International Cancer Research: Mesothelioma epidemic in Cappadocia: 2008-2010. (M. Tuncer, IY Baris, N. Cox, UA Dogan, HI.Pass, I. Steele, JR Testa, H. Yang, co PIs). USA-Australia Mesothelioma Consortium: NIH UO-1, 2006-2009. H.I. Pass PI, M. Carbone, co-pi. 16

THANKS! 17